Francesco Menzella

Montebelluna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 143 publications

Impact and management of biologic therapies on small airway dysfunction in severe asthma: a comprehensive review.

Impact and management of biologic therapies on small airway dysfunction in severe asthma: a comprehensive review.

Journal: Expert review of respiratory medicine

Published: August 31, 2026

Steroid-sparing biologics in severe asthma and chronic obstructive pulmonary disease: a systematic review, cross-disease meta-analysis, and translational estimate of corticosteroid-related harm prevented.

Steroid-sparing biologics in severe asthma and chronic obstructive pulmonary disease: a systematic review, cross-disease meta-analysis, and translational estimate of corticosteroid-related harm prevented.

Journal: European journal of internal medicine

Published: July 29, 2026

Dual REmission in moderate-to-severe AsthMa and nasal polyps: a multicentric observational phase IV real-life study (DREAM-NP).

Dual REmission in moderate-to-severe AsthMa and nasal polyps: a multicentric observational phase IV real-life study (DREAM-NP).

Journal: Expert opinion on biological therapy

Published: July 24, 2026

Sustained clinical remission over 24 months with tezepelumab in real-world severe uncontrolled asthma.

Sustained clinical remission over 24 months with tezepelumab in real-world severe uncontrolled asthma.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: June 23, 2026

Improved peripheral airway reactance is associated with clinical remission following biologic therapy in severe asthma.

Improved peripheral airway reactance is associated with clinical remission following biologic therapy in severe asthma.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: June 11, 2026

Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study.

Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study.

Journal: Expert opinion on biological therapy

Published: May 27, 2026

Combined large and small airway obstruction is associated with increased exacerbation frequency and poorer symptom control in persistent asthma.

Combined large and small airway obstruction is associated with increased exacerbation frequency and poorer symptom control in persistent asthma.

Journal: The journal of allergy and clinical immunology. In practice

Published: May 09, 2026

Small airway dysfunction: a key predictor of exacerbation risk in adolescents with mild, well-controlled asthma.

Small airway dysfunction: a key predictor of exacerbation risk in adolescents with mild, well-controlled asthma.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: April 14, 2026

A four-year journey towards clinical remission and background therapies optimization with benralizumab: A retrospective analysis.

A four-year journey towards clinical remission and background therapies optimization with benralizumab: A retrospective analysis.

Journal: The World Allergy Organization journal

Published: April 08, 2026

Time for proper physiological assessment: the role of cardiopulmonary exercise testing in helping step-up therapy in difficult-to-treat and severe asthma.

Time for proper physiological assessment: the role of cardiopulmonary exercise testing in helping step-up therapy in difficult-to-treat and severe asthma.

Journal: Expert review of respiratory medicine

Published: April 03, 2026

Dual clinical remission in severe asthma and chronic rhinosinusitis with nasal polyps: a comparative review of biologic therapies.

Dual clinical remission in severe asthma and chronic rhinosinusitis with nasal polyps: a comparative review of biologic therapies.

Journal: Expert opinion on biological therapy

Published: March 24, 2026

Dual Remission in Patients with Moderate-to-Severe Asthma and CRSwNP Treated with Dupilumab: A 24-Month Real-World Study.

Dual Remission in Patients with Moderate-to-Severe Asthma and CRSwNP Treated with Dupilumab: A 24-Month Real-World Study.

Journal: Journal of clinical medicine

Published: February 21, 2026

Showing 1-12 of 143

Last Updated: 09/26/2026